The epigenetic changes and the parallel increased risk of tumor onset occurring during aging keep open the possibility of a causative role of epigenetic reprogramming in RASSF1A silencing in support of progressive tumorigenesis. This evidence concerns the gene RASSF1 and neoplasm.